<SEC-DOCUMENT>0001493152-21-009928.txt : 20210428
<SEC-HEADER>0001493152-21-009928.hdr.sgml : 20210428
<ACCEPTANCE-DATETIME>20210428161602
ACCESSION NUMBER:		0001493152-21-009928
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210428
DATE AS OF CHANGE:		20210428

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Jemapete Christopher J
		CENTRAL INDEX KEY:			0001741021

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33635
		FILM NUMBER:		21864427

	MAIL ADDRESS:	
		STREET 1:		6888 SOUTH IRVINGTON COURT
		CITY:			AURORA
		STATE:			CO
		ZIP:			80016

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gene Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0000772320
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840635673
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11750 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 436-1000

	MAIL ADDRESS:	
		STREET 1:		11750 SORRENTO VALLEY ROAD
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Taxus Cardium Pharmaceuticals Group Inc.
		DATE OF NAME CHANGE:	20140318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardium Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cadium Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060118
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2021-03-31</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0000772320</issuerCik>
        <issuerName>Gene Biotherapeutics, Inc.</issuerName>
        <issuerTradingSymbol>CRXM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001741021</rptOwnerCik>
            <rptOwnerName>Jemapete Christopher J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>6888 S. IRVINGTON COURT</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>AURORA</rptOwnerCity>
            <rptOwnerState>CO</rptOwnerState>
            <rptOwnerZipCode>80016</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4000000</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Based on the issuer's annual report on Form 10-K, filed with the Securities and Exchange Commission on April 23, 2020, there were 49,622,154 shares of the issuer's common stock outstanding as of March 31, 2021. Accordingly, as of March 31, 2021, the reporting person beneficially owned less than 10% of the issuer's outstanding common stock.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Christopher J. Jemapete</signatureName>
        <signatureDate>2021-04-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
